BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 26498753)

  • 1. Tumorigenic hybrids between mesenchymal stem cells and gastric cancer cells enhanced cancer proliferation, migration and stemness.
    Xue J; Zhu Y; Sun Z; Ji R; Zhang X; Xu W; Yuan X; Zhang B; Yan Y; Yin L; Xu H; Zhang L; Zhu W; Qian H
    BMC Cancer; 2015 Oct; 15():793. PubMed ID: 26498753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell fusion between gastric epithelial cells and mesenchymal stem cells results in epithelial-to-mesenchymal transition and malignant transformation.
    He X; Li B; Shao Y; Zhao N; Hsu Y; Zhang Z; Zhu L
    BMC Cancer; 2015 Jan; 15():24. PubMed ID: 25633122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
    Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
    PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-treatment of human umbilical cord-derived mesenchymal stem cells with interleukin-6 abolishes their growth-promoting effect on gastric cancer cells.
    Wang M; Cai J; Huang F; Zhu M; Zhang Q; Yang T; Zhang X; Qian H; Xu W
    Int J Mol Med; 2015 Feb; 35(2):367-75. PubMed ID: 25483835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMT and acquisition of stem cell-like properties are involved in spontaneous formation of tumorigenic hybrids between lung cancer and bone marrow-derived mesenchymal stem cells.
    Xu MH; Gao X; Luo D; Zhou XD; Xiong W; Liu GX
    PLoS One; 2014; 9(2):e87893. PubMed ID: 24516569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusion with mesenchymal stem cells differentially affects tumorigenic and metastatic abilities of lung cancer cells.
    Zhang LN; Kong CF; Zhao D; Cong XL; Wang SS; Ma L; Huang YH
    J Cell Physiol; 2019 Apr; 234(4):3570-3582. PubMed ID: 30417342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SALL4, a novel marker for human gastric carcinogenesis and metastasis.
    Zhang L; Xu Z; Xu X; Zhang B; Wu H; Wang M; Zhang X; Yang T; Cai J; Yan Y; Mao F; Zhu W; Shao Q; Qian H; Xu W
    Oncogene; 2014 Nov; 33(48):5491-500. PubMed ID: 24276240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway.
    Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ
    Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting MAD2 modulates stemness and tumorigenesis in human Gastric Cancer cell lines.
    Pajuelo-Lozano N; Alcalá S; Sainz B; Perona R; Sanchez-Perez I
    Theranostics; 2020; 10(21):9601-9618. PubMed ID: 32863948
    [No Abstract]   [Full Text] [Related]  

  • 10. The promotion of the transformation of quiescent gastric cancer stem cells by IL-17 and the underlying mechanisms.
    Jiang YX; Yang SW; Li PA; Luo X; Li ZY; Hao YX; Yu PW
    Oncogene; 2017 Mar; 36(9):1256-1264. PubMed ID: 27524415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP signaling in gastric cancer-derived mesenchymal stem cells is critical for its promoting role in cancer progression.
    Pan Z; Tian Y; Zhang B; Zhang X; Shi H; Liang Z; Wu P; Li R; You B; Yang L; Mao F; Qian H; Xu W
    Int J Oncol; 2017 Oct; 51(4):1055-1066. PubMed ID: 28848999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    Ma X; Wang B; Wang X; Luo Y; Fan W
    PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colon cancer mesenchymal stem cells modulate the tumorigenicity of colon cancer through interleukin 6.
    Lin JT; Wang JY; Chen MK; Chen HC; Chang TH; Su BW; Chang PJ
    Exp Cell Res; 2013 Aug; 319(14):2216-29. PubMed ID: 23751564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway.
    Li T; Zhang C; Ding Y; Zhai W; Liu K; Bu F; Tu T; Sun L; Zhu W; Zhou F; Qi W; Hu J; Chen H; Sun X
    Oncol Rep; 2015 Sep; 34(3):1469-77. PubMed ID: 26151310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of CD105+/CD90+ subpopulation in breast cancer MDA-MB-231 cell line.
    Wang X; Liu Y; Zhou K; Zhang G; Wang F; Ren J
    Int J Clin Exp Pathol; 2015; 8(5):5105-12. PubMed ID: 26191205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.
    Zhou JY; Chen M; Ma L; Wang X; Chen YG; Liu SL
    Oncotarget; 2016 Feb; 7(7):7657-66. PubMed ID: 26840024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-β signaling.
    Hasegawa T; Yashiro M; Nishii T; Matsuoka J; Fuyuhiro Y; Morisaki T; Fukuoka T; Shimizu K; Shimizu T; Miwa A; Hirakawa K
    Int J Cancer; 2014 Apr; 134(8):1785-95. PubMed ID: 24155219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary study of side population cells in human gastric cancer cell line HGC-27.
    Gao G; Sun Z; Wenyong L; Dongxia Y; Zhao R; Zhang X
    Ann Transplant; 2015 Mar; 20():147-53. PubMed ID: 25773762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133+/CD166+ human gastric adenocarcinoma cells present the properties of neoplastic stem cells and emerge more malignant features.
    Ni T; Wang H; Zhan D; Tao L; Lv M; Wang W; Chu Z; Zhou Z; Sunagawa M; Liu Y
    Life Sci; 2021 Mar; 269():119021. PubMed ID: 33450261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells.
    Ma Y; Hao X; Zhang S; Zhang J
    Breast Cancer Res Treat; 2012 Jun; 133(2):473-85. PubMed ID: 21947651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.